Author:
Murray KS,Newman PJ,Gatehouse BM,Taylor D
Abstract
The title compound, which
previously had been isolated from bacteria and shown to possess anti-bacterial
activity, has been chemically synthesized. The molecular structure has a cis
(facial) arrangement of the asymmetric {S,O} bidentate ligands (Fe-S 2.441(1)
Ǻ, Fe-O 2.010(1) Ǻ) as required by the crystallographic C3
molecular symmetry. (Crystal data: C6H12N3O3S3Fe,
rhombohedral, space group R3, a 7.094(2)Ǻ, α 102.00(1)°, Z 1.) The
complex was spontaneously resolved into enantiomers on crystallization and the
absolute configuration in the crystal studied was established as Λ by the
anomalous dispersion technique. Magnetic, e.s.r. and Mossbauer studies are
compatible with a distorted octahedral complex of high-spin iron(III). Cyclic
voltammetric studies in acetone of the title compound and some related iron(III)
thiohydroxamates were carried out. A reversible FeIII/FeII
reduction wave was observed for the N-methylformothiohydroxamato chelate, in
contrast to the irreversible reduction of tris(benzohydroxamato)iron(III),
a related complex containing an {O,O} chelate. The tris(benzothiohydroxamato)
chelate, Fe(PhC(S)NHO)3, which possesses a
non-alkylated nitrogen, also showed an irreversible reduction wave.